Phospho-MAP2K4 (S257) Antibody

What is MAP2K4 and its significance in cellular signaling?

MAP2K4 (also known as MEK4 or MKK4) is a dual specificity protein kinase that acts as an essential component of the MAP kinase signal transduction pathway. It functions within a three-tiered signaling module (MAPKKKs → MAPKKs → MAPKs) and serves as an integration point for multiple biochemical signals . MAP2K4 is primarily involved in the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway and is critical for various cellular processes including proliferation, differentiation, transcription regulation, and development .

What is the significance of the S257 phosphorylation site on MAP2K4?

Phosphorylation at Serine 257 (S257) is one of the key activation mechanisms for MAP2K4. MAP2K4 is activated by upstream MAP kinase kinase kinases (MAP3Ks) through phosphorylation at two sites: Serine 257 and Threonine 261 . The S257 phosphorylation is essential for MAP2K4's catalytic activity, enabling it to phosphorylate downstream MAPK targets at threonine and tyrosine residues, particularly JNK and p38 MAPKs . This post-translational modification serves as a crucial regulatory checkpoint in the MAPK signaling cascade.

What are the typical applications for Phospho-MAP2K4 (S257) antibodies?

Phospho-MAP2K4 (S257) antibodies are used in multiple experimental applications:

These antibodies allow researchers to monitor the activation status of MAP2K4 in various experimental contexts .

How should I design experiments to detect Phospho-MAP2K4 (S257) in cell culture models?

For optimal detection of Phospho-MAP2K4 (S257) in cell culture:

• Cell stimulation: Treat cells with appropriate stimuli to induce MAP2K4 phosphorylation

  • Stress inducers: 300 mM sorbitol (30 minutes)

  • Inflammatory stimuli: 10 ng/mL recombinant IL-1β (20 minutes)

  • Growth factors: PDGF treatment for PC-3 cells

• Sample preparation:

  • Rapidly lyse cells in phosphatase inhibitor-containing buffer

  • Maintain samples at 4°C throughout processing

  • Use freshly prepared lysates when possible to prevent dephosphorylation

• Controls:

  • Include untreated cells as negative controls

  • Use phosphatase-treated samples (e.g., with Calf Intestinal Phosphatase) as specificity controls

  • Consider including positive control lysates from HeLa cells

The expected molecular weight for detection is approximately 44-45 kDa .

What are the optimal protocols for Western blot analysis using Phospho-MAP2K4 (S257) antibodies?

For Western blot analysis of Phospho-MAP2K4 (S257):

• Sample preparation:

  • Use RIPA or similar lysis buffer containing protease and phosphatase inhibitors

  • Load 20-50 μg of total protein per lane

• Electrophoresis and transfer:

  • Separate proteins using 10-12% SDS-PAGE

  • Transfer to PVDF membrane (preferred over nitrocellulose for phospho-epitopes)

• Antibody incubation:

  • Block with 5% BSA (preferred over milk for phospho-antibodies)

  • Incubate with primary antibody at 1:500-1:2000 dilution overnight at 4°C

  • Use HRP-conjugated secondary antibody (e.g., anti-rabbit IgG)

• Detection:

  • Visualize using ECL detection system

  • Expected band at approximately 44 kDa

• Troubleshooting:

  • If background is high, increase blocking time or washing steps

  • If signal is weak, consider longer exposure or higher antibody concentration

How can I validate the specificity of Phospho-MAP2K4 (S257) antibody detection?

To validate antibody specificity:

• Phosphatase treatment control:

  • Treat duplicate samples with lambda phosphatase or CIP

  • Loss of signal in treated samples confirms phospho-specificity

• Peptide competition assay:

  • Pre-incubate antibody with immunizing phosphopeptide

  • Specific antibodies will show diminished signal

• Knockdown/knockout controls:

  • Use siRNA against MAP2K4 to confirm specificity

  • MAP2K4 knockout samples should show no signal

• Stimulation-dependent phosphorylation:

  • Compare basal vs. stimulated conditions

  • Phosphorylation should increase with appropriate stimuli

• Cross-reactivity assessment:

  • Test across multiple species using samples from human, mouse, and rat sources

How does dual phosphorylation at S257/T261 differ from single S257 phosphorylation?

Understanding the differential effects of single versus dual phosphorylation:

• Activation mechanism:

  • S257 phosphorylation is necessary but not always sufficient for full MAP2K4 activation

  • Dual phosphorylation at S257/T261 results in maximal kinase activity

• Functional implications:

  • Single S257 phosphorylation may represent an intermediate activation state

  • Dual phosphorylation enhances substrate specificity and catalytic efficiency

• Experimental approach to distinguish:

  • Use antibodies specific for single phosphorylation (S257 only) vs. dual phosphorylation (S257/T261)

  • Perform kinase activity assays to correlate phosphorylation status with functional output

  • Employ phospho-mimetic mutations (S→D, T→E) to study the contribution of individual sites

• Temporal dynamics:

  • Monitor the kinetics of S257 vs. S257/T261 phosphorylation after stimulation

  • Different stimuli may induce different phosphorylation patterns and kinetics

What is the relationship between MAP2K4 phosphorylation and its role in cancer biology?

MAP2K4 phosphorylation has complex roles in cancer development and progression:

• Dual role in cancer:

  • MAP2K4 shows context-dependent functions as both tumor suppressor and oncogene

  • Loss-of-function mutations found in lung and pancreatic tumors suggest tumor suppressor role

  • Conversely, MAP2K4 overexpression promotes cancer cell proliferation and invasion in breast cancer

• Signaling pathway interactions:

  • MAP2K4 phosphorylation affects downstream JNK and p38 MAPK activation

  • In breast cancer, MAP2K4 activates PI3K/AKT pathway to promote proliferation, migration, and invasion

• Experimental approaches:

  • Measure phospho-MAP2K4 (S257) levels in tumor vs. normal tissue samples

  • Correlate phosphorylation status with clinical outcomes

  • Use phospho-MAP2K4 (S257) antibodies in tissue microarrays for prognostic studies

• Therapeutic implications:

  • Monitor phospho-MAP2K4 (S257) as a biomarker for drug response

  • Target MAP2K4 phosphorylation or its upstream/downstream effectors therapeutically

How can I study the subcellular localization of phosphorylated MAP2K4?

For investigating subcellular distribution of phosphorylated MAP2K4:

• Immunofluorescence protocol optimization:

  • Fix cells with 4% paraformaldehyde (10 min at room temperature)

  • Permeabilize with 0.1% Triton X-100

  • Block with 1-5% BSA

  • Incubate with phospho-MAP2K4 (S257) antibody (1:50-1:200 dilution)

  • Use fluorophore-conjugated secondary antibody (e.g., NorthernLights™ 557-conjugated anti-rabbit IgG)

  • Counter-stain nuclei with DAPI

• Subcellular fractionation approach:

  • Separate nuclear, cytoplasmic, and membrane fractions

  • Analyze phospho-MAP2K4 (S257) levels in each fraction by Western blot

  • Compare distribution patterns under basal vs. stimulated conditions

• Expected localization pattern:

  • Phosphorylated MAP2K4 has been detected in both nucleus and cytoplasm

  • Distribution patterns may change with different stimuli or cell types

• Co-localization studies:

  • Combine with markers for specific organelles (ER, Golgi, mitochondria)

  • Use confocal microscopy for high-resolution co-localization analysis

Why might I observe weak or variable phospho-MAP2K4 (S257) signals?

Common issues affecting phospho-MAP2K4 (S257) detection and solutions:

• Phosphatase activity issues:

  • Problem: Rapid dephosphorylation during sample preparation

  • Solution: Add phosphatase inhibitors to all buffers; keep samples cold; process rapidly

• Low basal phosphorylation:

  • Problem: Minimal S257 phosphorylation under basal conditions

  • Solution: Stimulate cells appropriately (sorbitol, IL-1β, other stress inducers)

• Antibody quality/sensitivity:

  • Problem: Batch-to-batch variation in antibody performance

  • Solution: Validate each new lot; consider antibodies from manufacturers with consistent quality control

• Sample preparation issues:

  • Problem: Epitope masking or destruction during preparation

  • Solution: Test different lysis methods; avoid harsh detergents; optimize protein denaturation conditions

• Timing considerations:

  • Problem: Transient phosphorylation missed during analysis

  • Solution: Perform time-course experiments to identify optimal time points for detection

How can I optimize Phospho-MAP2K4 (S257) antibody for immunohistochemistry?

For optimal IHC results with phospho-MAP2K4 (S257) antibody:

• Tissue preparation:

  • Use freshly fixed tissues whenever possible

  • Employ phosphatase inhibitors during fixation

  • Consider rapid fixation protocols to preserve phospho-epitopes

• Antigen retrieval optimization:

  • Test multiple methods (heat-mediated vs. enzymatic)

  • For heat-mediated retrieval, try citrate buffer (pH 6.0) vs. EDTA buffer (pH 9.0)

  • Optimize retrieval time (typically 10-20 minutes)

• Antibody conditions:

  • Dilution range: 1:50-1:200 for IHC applications

  • Incubation time: Overnight at 4°C may yield better results than shorter incubations

  • Consider signal amplification systems for low-abundance targets

• Controls:

  • Include phosphatase-treated sections as negative controls

  • Use tissues known to express activated MAP2K4 as positive controls

• Detection systems:

  • DAB vs. fluorescent detection (choose based on research needs)

  • Polymer-based detection systems may provide higher sensitivity

What is the best way to quantify changes in MAP2K4 S257 phosphorylation?

Methods for quantitative analysis of MAP2K4 S257 phosphorylation:

• Western blot densitometry:

  • Normalize phospho-signal to total MAP2K4 expression

  • Use digital image analysis software for accurate quantification

  • Include standard curves with known amounts of phosphorylated protein

• Phospho-flow cytometry:

  • Enables single-cell analysis of phosphorylation status

  • Requires optimization of fixation and permeabilization protocols

  • Can be combined with other cellular markers

• ELISA-based quantification:

  • Commercial ELISA kits may be available

  • Consider developing sandwich ELISA using total MAP2K4 capture antibody and phospho-specific detection antibody

  • Provides more precise quantification than Western blot

• Mass spectrometry approaches:

  • Absolute quantification of phosphorylation stoichiometry

  • Can detect multiple phosphorylation sites simultaneously

  • Requires specialized equipment and expertise

• Phospho-protein arrays:

  • Multiplex analysis of MAP2K4 alongside other signaling proteins

  • Useful for pathway analysis and network mapping

What are the optimal storage conditions for Phospho-MAP2K4 (S257) antibodies?

For maximum antibody performance and longevity:

• Temperature requirements:

  • Store at -20°C for long-term storage

  • Some antibodies can be stored at 4°C for short-term use (up to 1 week)

• Physical form considerations:

  • Most phospho-MAP2K4 (S257) antibodies are supplied in liquid form

  • Typical storage buffer: PBS with 50% glycerol, 0.02% sodium azide, and sometimes 0.5% BSA

• Aliquoting recommendations:

  • Divide into small single-use aliquots to avoid freeze-thaw cycles

  • Typical working aliquots: 10-20 μL depending on application needs

• Stability parameters:

  • Generally stable for 12 months at -20°C

  • Avoid repeated freeze-thaw cycles as they can degrade antibody quality

• Handling precautions:

  • Allow antibody to reach room temperature before opening vial

  • Centrifuge briefly before opening to collect liquid at the bottom of the tube

  • Return to -20°C promptly after use